Increased proportion of a CD38highIgD+ B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sjögren's syndrome

Copyright © 2017 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 187(2018) vom: 01. Feb., Seite 85-91
1. Verfasser: Ishioka-Takei, Eriko (VerfasserIn)
Weitere Verfasser: Yoshimoto, Keiko, Suzuki, Katsuya, Nishikawa, Ayumi, Yasuoka, Hidekata, Yamaoka, Kunihiro, Takeuchi, Tsutomu
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Autoantibodies B cell CD38 ESSDAI IgD IgG Sjögren's syndrome Antibodies, Antinuclear mehr... Antigens, CD19 Immunoglobulin D Immunoglobulin G SS-A antibodies SS-B antibodies ADP-ribosyl Cyclase 1 EC 3.2.2.6
LEADER 01000caa a22002652 4500
001 NLM277298180
003 DE-627
005 20250222121657.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2017.10.008  |2 doi 
028 5 2 |a pubmed25n0924.xml 
035 |a (DE-627)NLM277298180 
035 |a (NLM)29061446 
035 |a (PII)S1521-6616(17)30641-1 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Ishioka-Takei, Eriko  |e verfasserin  |4 aut 
245 1 0 |a Increased proportion of a CD38highIgD+ B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sjögren's syndrome 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 18.03.2019 
500 |a Date Revised 18.03.2019 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2017 Elsevier Inc. All rights reserved. 
520 |a We investigated the correlation between the increased proportion of peripheral B cell subsets and clinical and immunological features in primary Sjögren's syndrome (pSS). We found that the proportion of CD19+ B cells was significantly increased in pSS as compared with HC and was correlated with serum IgG levels. Moreover, in vitro IgG production by CD19+ B cells was significantly increased in pSS and was positively and significantly correlated with serum IgG levels. FACS analysis revealed that the proportions of peripherally CD38highIgD+ B cells and CD38highIgD- B cells were significantly increased in pSS. In addition, the proportion of CD38highIgD+ B cells positively correlated with ESSDAI scores and serum levels of IgG, anti-Ro/SSA and anti-La/SSB antibodies while that of CD38highIgD- B cells showed no correlation with these parameters. Our data suggest that increased proportion of CD38highIgD+ B cells in pSS is involved in IgG overproduction including autoantibodies, and correlates with disease progression 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Autoantibodies 
650 4 |a B cell 
650 4 |a CD38 
650 4 |a ESSDAI 
650 4 |a IgD 
650 4 |a IgG 
650 4 |a Sjögren's syndrome 
650 7 |a Antibodies, Antinuclear  |2 NLM 
650 7 |a Antigens, CD19  |2 NLM 
650 7 |a Immunoglobulin D  |2 NLM 
650 7 |a Immunoglobulin G  |2 NLM 
650 7 |a SS-A antibodies  |2 NLM 
650 7 |a SS-B antibodies  |2 NLM 
650 7 |a ADP-ribosyl Cyclase 1  |2 NLM 
650 7 |a EC 3.2.2.6  |2 NLM 
700 1 |a Yoshimoto, Keiko  |e verfasserin  |4 aut 
700 1 |a Suzuki, Katsuya  |e verfasserin  |4 aut 
700 1 |a Nishikawa, Ayumi  |e verfasserin  |4 aut 
700 1 |a Yasuoka, Hidekata  |e verfasserin  |4 aut 
700 1 |a Yamaoka, Kunihiro  |e verfasserin  |4 aut 
700 1 |a Takeuchi, Tsutomu  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 187(2018) vom: 01. Feb., Seite 85-91  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:187  |g year:2018  |g day:01  |g month:02  |g pages:85-91 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2017.10.008  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 187  |j 2018  |b 01  |c 02  |h 85-91